Dual PI3K/mTOR inhibitor PF-04979064 regulates tumor growth in gastric cancer and enhances drug sensitivity of gastric cancer cells to 5-FU-Reference-Cited by-同舟云学术

Dual PI3K/mTOR inhibitor PF-04979064 regulates tumor growth in gastric cancer and enhances drug sensitivity of gastric cancer cells to 5-FU

Published:2024-01 Issue: Volume:170 Page:116086
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

Zhong Ziyuan,Wang Tengkai,Zang Ruochen,Zang Yufei,Feng Yaoyao,Yan Shujun,Geng Congcong,Zhu Na,Wang Qian

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference35 articles.

1. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 Countries;Sung;CA: A Cancer J. Clin.,2021

2. Gastric cancer and family history;Choi;Korean J. Intern. Med.,2016

3. Integrative single-cell multiomics analyses dissect molecular signatures of intratumoral heterogeneities and differentiation states of human gastric cancer;Bian;Natl. Sci. Rev.,2023

4. Discovery of the highly potent PI3K/mTOR dual inhibitor PF-04979064 through structure-based drug design;Cheng;ACS Med. Chem. Lett.,2012

5. The PI3K/AKT/mTOR pathway regulates autophagy to induce apoptosis of alveolar epithelial cells in chronic obstructive pulmonary disease caused by PM2.5 particulate matter;Zhang;J. Int. Med. Res.,2020

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Obesity-Associated Colorectal Cancer;International Journal of Molecular Sciences;2024-08-14

2. EGFR and PI3K Signalling Pathways as Promising Targets on Circulating Tumour Cells from Patients with Metastatic Gastric Adenocarcinoma;International Journal of Molecular Sciences;2024-05-20